Health Care Technology
Company Overview of GNS Healthcare, Inc.
GNS Healthcare, Inc., a healthcare data analytics company, provides healthcare science and technology that applies machine learning and simulation technologies to understand patient treatments. It offers Reverse Engineering and Forward Simulation that automates the extraction of causal network models directly from observational data and uses high-throughput simulations to generate new knowledge. Its analytics solutions are applied across the healthcare industry that ranges from pharmaceutical and biotechnology companies, health plans, and hospitals to integrated delivery systems, pharmacy benefits managers, and accountable care organizations. GNS Healthcare, Inc. was formerly known as GNS Bi...
58 Charles Street
Cambridge, MA 02141
Founded in 2000
Key Executives for GNS Healthcare, Inc.
Co-Founder and Executive Vice President
Chief Financial Officer and Chief Operating Officer
Vice President of Science and Technology
Compensation as of Fiscal Year 2012.
GNS Healthcare, Inc. Key Developments
GNS Healthcare, Inc. Presents at Boston Biotech Conference, Apr-03-2013 02:30 PM
Mar 30 13
GNS Healthcare, Inc. Presents at Boston Biotech Conference, Apr-03-2013 02:30 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: Colin Hill, Co-Founder, Chairman of the Board, Chief Executive Officer and President.
GNS Healthcare, Inc. Presents at Lazard Capital Markets, LLC's 9th Annual Healthcare Conference, Nov-13-2012 01:30 PM
Nov 12 12
GNS Healthcare, Inc. Presents at Lazard Capital Markets, LLC's 9th Annual Healthcare Conference, Nov-13-2012 01:30 PM. Venue: The Pierre Hotel, 2 East 61st Street, New York, New York, United States. Speakers: Colin Hill, Co-Founder, Chairman of the Board, Chief Executive Officer and President.
GNS Healthcare, Inc. Appoints Hans Winkler as Chief Scientific Officer
Oct 11 12
GNS Healthcare, Inc. announced the expansion of its senior management team, adding Hans Winkler, Ph.D., as Chief Scientific Officer. Dr. Winkler will promote the development of the company's intellectual property, building out product infrastructure and fostering the overall scientific strategy for the company's product offerings to the pharmaceutical and biotechnology industry as well as academia. He was most recently Senior Director and Global Oncology Biomarker Program Leader within Janssen Oncology Research and Development, a division of Johnson & Johnson.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|